Abstract
Charlotte Barker, Commissioning Editor, speaks to JoAnn E Manson about the key findings from KEEPS and implications for clinicians treating newly menopausal womenJoAnn E Manson is Chief of the Division of Preventive Medicine, as well as Co-Director of the Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital, Harvard Medical School (MA, USA). She is the Michael and Lee Bell Professor of Women's Health and Professor of Medicine at Harvard Medical School. Dr Manson received her AB from Harvard University (MA, USA), her MD from Case Western Reserve University School of Medicine (OH, USA), and an MPH and DrPH from the Harvard School of Public Health. She is board-certified in both Internal Medicine and the subspecialty of Endocrinology and Metabolism. Her major research interests include preventive medicine and randomized clinical trials, particularly for prevention of cardiovascular disease, diabetes and cancer in women. She is Principal Investigator of several grants from the National Institutes of Health, including the VITamin D and OmegA-3 TriaL, the Women's Health Initiative Vanguard Clinical Center at Brigham and Women's Hospital in Boston, the Women's Antioxidant and Folic Acid Cardiovascular Trial, and Biochemical and Genetic Risk Factors for CVD in Women. She is also Principal Investigator of the Boston site for the Kronos Early Estrogen Prevention Study (KEEPS), which recently reported preliminary results suggesting a number of positive effects of hormone therapy for newly menopausal women.
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Access to resources
Recommend
